June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Acylcarnitine metabolism is altered between retina and RPE/Choroid tissues in laser-induced choroidal neovascularization model rats
Author Affiliations & Notes
  • Guoge Han
    Retina, Tianjin Eye Hospital, Tianjin, Tianjin, China
  • Pinghui Wei
    Retina, Tianjin Eye Hospital, Tianjin, Tianjin, China
  • Footnotes
    Commercial Relationships   Guoge Han None; Pinghui Wei None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 3512. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Guoge Han, Pinghui Wei; Acylcarnitine metabolism is altered between retina and RPE/Choroid tissues in laser-induced choroidal neovascularization model rats. Invest. Ophthalmol. Vis. Sci. 2023;64(8):3512.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Mitochondrial dysfunction, characterized by abnormal acylcarnitine, has been found during metabolic screening of serum or other body tissues in wet age-related macular degeneration (AMD). Although regarded as potential diagnostic markers, whether defect in acylcarnitine metabolism contributes to the pathophysiology of wet AMD on retina and RPE/choroid remains unclear. This study aimed to investigate carnitine shuttle pathway in a laser induced choroidal neovascularization (CNV) model.

Methods : Chow Diet (CD) and high fat diet (HFD) BN rats were laser treated to induce CNV. A global untargeted metabolomics study was performed between NC and CNV model. Ultrahigh-performance liquid chromatography tandem mass spectrometry was used to quantitatively characterize acylcarnitine species. OCT and FFA were employed to evaluate CNV severity. Western blotting was used to analyze key glycolytic enzymes.

Results : In the CD+CNV model, a few medium chain fatty acid (MCFA) acylcarnitine in the RPE/Choroid were initially affected; when high fat diet was given to the CNV model, even MCFA acylcarnitine in the RPE /Choroid was found to decline, compared with the CNV group. By contrast, in the retina, odd acylcarnitine, proposed as potential biomarkers for the metabolic syndrome, showed an upward trend revealing "reverse or separate" change with RPE/Choroid, accompanied by influencing glycolytic key enzymes. While comparing HFD+CNV with the control group, we found that few, long-chain acyl carnitine, such as (C18:2) was characterized by incorporation in the retina.

Conclusions : In conclusion, we documented comprehensive acylcarnitine profiles in CNV model which expands the palette of acylcarnitine with treatment potential, derived from odd-even and carbon chain length.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×